Design Therapeutics, Inc. (DSGN)
NASDAQ: DSGN · Real-Time Price · USD
5.45
+0.47 (9.44%)
Aug 13, 2025, 4:00 PM - Market closed
Design Therapeutics Market Cap
Design Therapeutics has a market cap or net worth of $308.66 million as of August 14, 2025. Its market cap has increased by 9.27% in one year.
Market Cap
308.66M
Enterprise Value
94.33M
1-Year Change
9.27%
Ranking
Category
Stock Price
$5.45
Market Cap Chart
Since the IPO on March 26, 2021, Design Therapeutics's market cap has decreased from $2.21B to $308.66M, a decrease of -86.01%. That is a compound annual growth rate of -36.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 308.66M | -11.65% |
| Dec 31, 2024 | 349.35M | 135.41% |
| Dec 29, 2023 | 148.40M | -74.10% |
| Dec 30, 2022 | 572.92M | -51.55% |
| Dec 31, 2021 | 1.18B | -46.40% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 592.95B |
| Johnson & Johnson | 420.06B |
| AbbVie | 355.91B |
| UnitedHealth Group | 246.17B |
| AstraZeneca | 240.81B |
| Novartis AG | 234.72B |
| Novo Nordisk | 227.37B |
| Abbott Laboratories | 225.22B |